Press Releases
Contributing to the Discussion on Rare Diseases
Read the latest updates and announcements from ITF Therapeutics.
For the Media
USA
Media inquiries: Emily Steinhauer | +1 212 253 8881 | [email protected]
Other inquiries: Martha McKennitt, Head of Corporate Communications | [email protected]
